Advertisement
Central Surgical Association| Volume 142, ISSUE 4, P581-587, October 2007

Evaluation and management of incidental thyroid nodules in patients with another primary malignancy

      Background

      Studies indicate that incidentally discovered thyroid nodules ≥1 cm in size may have a higher rate of malignancy (7% to 29%) than traditionally discovered nodules (5%). We sought to determine the rate of malignancy in incidental thyroid nodules in patients with other malignancies, and examine the accuracy of ultrasound (US) versus computed tomography (CT) in determining nodule size.

      Methods

      We evaluated 41 patients with history of another known malignancy (gastrointestinal, 23; breast, 11; other, 7) referred with an incidental thyroid nodule. Patients underwent office-based US and biopsy of nodules ≥1 cm. Surgical intervention was based on biopsy results. We compared nodule size at pathology with size seen on CT or US.

      Results

      Thirty-five patients met criteria for biopsy. Of the 35, 20 (57%) had atypical biopsy results warranting resection. Sixteen of those 20 underwent surgery. Pathology yielded 4 papillary thyroid cancers (PTC), 4 microPTC, 2 metastatic cancers, and 7 benign lesions. Ultrasound measurement of nodules compared to size measured at pathology had an r2 correlation value of 0.90 with P value <.0001. CT scan had an r2 value of 0.83 and P value of .005.

      Conclusions

      Incidental thyroid nodules in patients with another primary malignancy warranted resection in 57%. The rate of malignancy in incidental thyroid nodules was 24%, which is above the expected rate of 5% seen in traditionally discovered nodules. US correlation with nodule size at pathology was excellent and superior to CT scan. Incidentally discovered thyroid nodules ≥1 cm, seen in patients with another malignancy, warrant further evaluation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Brander A.
        • Viikinkowski P.
        • Nickels J.
        • Kivisaari L.
        Thyroid gland: US screening in a random adult population.
        Radiology. 1991; 181: 683-687
        • Ezzat S.
        • Sarti D.A.
        • Cain D.R.
        • Braunstein G.D.
        Thyroid incidentalomas.
        Ann Intern Med. 1994; 154: 1838-1840
        • Steele S.R.
        • Martin M.J.
        • Mullenix P.S.
        • Azarow K.S.
        • Anderson C.A.
        The significance of incidental thyroid abnormalities identified during carotid duplex ultrasonography.
        Arch Surg. 2005; 140: 981-985
        • Cohen M.S.
        • Nuri A.
        • Dehdashti F.
        • Doherty G.M.
        • Lairmore T.C.
        • Brunt L.M.
        • et al.
        Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
        Surgery. 2001; 130: 941-946
        • Shetty S.K.
        • Maher M.M.
        • Hahn P.F.
        • Halpern E.F.
        • Aquino S.L.
        Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology.
        AJR. 2006; 187: 1349-1356
        • Garancini S.
        • La Rosa S.
        • De Palma D.
        • Uccella S.
        • Golonia F.
        Uptake in In-111 pentreotide by normally functioning nodular goiters.
        Clin Nuclear Med. 1997; 22: 625-627
        • Vander J.B.
        • Gaston E.A.
        • Dawber T.R.
        The significance of nontoxic thyroid nodules: final report of a fifteen year study of the incidence of thyroid malignancy.
        Ann Intern Med. 1968; 69: 537-540
        • Turnbridge W.M.
        • Evered D.C.
        • Hall R.
        • Appleton D.
        • Brewis M.
        • Clark F.
        • et al.
        The spectrum of thyroid disease in a community: the Whickham survey.
        Clin Endocrinol. 1977; 7: 481-493
        • Mortensen J.D.
        • Woolner L.B.
        • Bennett W.A.
        Gross and microscopic findings in clinically normal thyroid glands.
        J Clin Endocrinol Metab. 1955; 15: 1270-1280
        • Kang H.W.
        • No J.H.
        • Chung J.H.
        • Min Y.K.
        • Lee M.S.
        • Lee M.K.
        • et al.
        Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas.
        Thyroid. 2004; 14: 29-33
        • Liebeskind A.
        • Sikora A.G.
        • Komisar A.
        • Slavit D.
        • Fried K.
        Rates of malignancy in incidentally discovered thyroid nodules with sonography and fine needle aspiration.
        J Ultrasound Med. 2005; 24: 629-634
        • Papini E.
        • Guglielmi R.
        • Bianchini A.
        • Crescenzi A.
        • Taccogna S.
        • Nardi F.
        • et al.
        Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features.
        J Clin Endocrin Metab. 2002; 87: 1941-1946
        • Ross D.S.
        Editorial: nonpalpable thyroid nodules–managing an epidemic.
        J Clin Endocrinol Metab. 2002; 87: 1938-1940
        • Fukunaga F.H.
        • Yatani R.
        Geographic pathology of occult thyroid carcinoma.
        Cancer. 1975; 36: 1095-1099
        • Delbridge L.
        Solitary thyroid nodule: current management.
        Aust N Z J Surg. 2006; 76: 381-386